Hematologic Malignancies

Slides:



Advertisements
Similar presentations
Introduction to Leukemia
Advertisements

TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
A Hematology Case Study about Leukemia by Sarah Wycoff
Leukemia Leukemia is a general term for a group of malignancies of either lymphoid or hematopoietic cell origin.
Acute leukemia Mohammed Al-matrafi.
Introduction To Haematological Malignancies
1 Leukemia. 2 Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of A group of malignant disorders affecting the blood.
LEUKEMIA.
LEUKEMIA—HEMATOLOGY {S1}
Acute Lymphoblastic Leukemia Maggie Davis Hovda 5/26/2009.
Leukemias.
Leukemia and Lymphoma Dental Views By Fatin Al – Sayes MD, Msc,FRcpath Associate Professor Consultant Hematology Leukemia and Lymphoma Dental Views By.
Myelodysplastic Syndrome
Introduction to Leukemia
ACUTE MYELOID LEUKEMIA Irit Avivi
Leukemia Maturation of Myeloid Cells Dr. Rania Alhady.
Identification and Diagnosis of the Acute Leukemias
LEUKEMIAS Dr Mehboob Khan Pathologist
Acute leukemia Aggressive malignant hematopoietic disorders
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
HEMATOLOGIC MALIGNANCIES Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic.
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Acute Myeloid Leukemias (AML)
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
Jan Żeromski Pathology 2010/2011.  Malignant proliferation of white cells of the hematopoietic system with infestation of blood and usually bone marrow.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Myeloproliferative Disorders (MPDs)
Cancer of the blood: Leukemia
MOLECULAR GENETICS and LEUKEMIA Clive S. Zent M.D. Division of Hematology/Oncology.
Morphology Review - ISH Slides - 제 2 차 혈액학 종합학술대회 발표 2000 년 5 월 25 일 -5 월 26 일 COEX 한림의대 조 현 찬.
CLINICAL LABORATORY DIAGNOSTICS OF HEMOBLASTOSIS
4th Year Medical Student KAU
Acute Lymphoblastic Leukaemia Terri Boyer 17 th October 2006.
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Clinical laboratory diagnostics of hemoblastosis.
Associate professor of Internal Medicine
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
Acute myeloid leukemia
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
MLAB 1415: Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 28 Disorders of White Blood Cells and Lymphoid Tissues.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
(NAAC Accredited ‘A’ grade)
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Acute Leukemia Kristine Krafts, M.D..
Malignancies of hematopoietic cells. Leukemia
Acute myeloid leukemia
Acute Myeloid Leukemia
LEUKEMIAS H.A. MWAKYOMA, MD.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Leukemias.
Acute Myeloid Leukemia
Case Study ….
Acute leukemia.
LEUKEMIA CASE STUDY 2.
Diagnostic Hematology
Erythroid maturation.
بسم الله الرحمن الرحيم Acute lymphoid leukemia(ALL) Prepared by ::
A presentation By Abedelaziz Taha Hammash supervisor \ Mr
Acute Leukemia Dr. Noha Noufal.
Neoplastic disorder.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
MYELOID LEUKEMIAS Dr. B.V.Vydehi M.D PROFESSOR OF PATHOLOGY
Presentation transcript:

Hematologic Malignancies Acute Leukemia

Definition Leuko = white Emia = blood Acute Leukemia: is a stem cell malignant disorder characterized by abnormal proliferation of malignant clone in uncontrolled fashion. It is a bone marrow based malignancy where expansion of the malignant clone interfere with normal BM function

Types Acute leukemia: runs a rapid and explosive course. Chronic Leukemia: runs a more protracted and less severe course.

Etiology Exact cause: Still unknown? Possible etiologic associations: 1- Radiation- Ionizing radiation exposure increases incidence of AL. Evidence from atomic bomb survivors in Japan & ankylosing spondylitis patients were treated with radiotherapy. No risk from diagnostic radiation in patients & medical personnel.

2- V iruses: Oncogenic viruses HTLV-I associated with ATLL HTLV-II causes in experimental animals a syndrome similar to Hairy cell Leukemia

3- Genetics: Increased AL in hereditary diseases with chromosomal instability AR- Ataxia-telangiectasia - Bloom syndrome - Fanconi Anemia X-linked infantile agammaglobulinemia Others- Down’s synd, Turner, Kleinfelter

Inv 16 – AML M4 t( 9;22) Ph + ALL, AML, CML t(15;17) – AML M3 t(10;14)(q24;q11) – ALL t(8;14)(q24;q32) Hyperdiploidy

4- Chemicals: Benzene, insecticides, pesticides, herbicides Drugs: Alkylating agents- CTx, chlorambucil, melphalan Nitrosoureas, etoposide Bimolane – used for psoriasis

5- Chronic BM stem cell disease e. g. PNH,AA,MDS 5- Chronic BM stem cell disease e.g. PNH,AA,MDS ....etc Others- Potent EM fields - smoking

Epidemiology More in developed countries Male > female ALL in children > adults

classification FAB (Frech-American-British) 1- Acute lymphoblastic Leukemia (ALL) L1 in children L2 in adults L3 Burkitt-lymphoma-like 2- Acute myeloblastic Leukemia (AML)

AML M0 – acute undifferentiated leukemia M1 - AML with minimal differentiation M2- AML with differentiation M3- Acute promyelocytic Leukemia M4 – Acute myelomonoblastic leuk M4E – with peripheral eosinophilia M5- Acute monoblastic leukemia M6- Acute erythroleukemia M7- Acute megakaryoblastic leukemia

Clinical Manifestations Dx suspected in presence of Triad ( Anemia, fever & bleeding) due to BM occupation blasts Anemia- pallor, palpitation, easy fatigue, anorexia, SOB, Chest pain, dizziness Fever- due to neutropenia & infection ( G-ve bacilli, coagulase –ve staph, viruses, fungi...) Bleeding- hemorrhage into skin (petechiae, purpura, ecchymoses, bruises), gum, mucosae

Bone pain may be so severe that mimic JCA Hepatosplenomegaly – ALL > AML Lymphadenopathy – ALL > AML Peculiar features- Soft tissues myeloblastoma (Chloroma) – AML Cutaneous infiltration – M4,M5 Meningeal infiltration- ALL< M4,M5 Testicular infiltration- ALL Gum hypertrophy- M4,M5 Lactic acidosis- L3 Prolonged prodromal phase- M6 BM fibrosis- M7 Leukostasis- AML

Lab Dx CBC- Anemia- Hb low, platelets low - WBC may be increased (if >50000 risk of hyperleukocytosis), may be normal, may be decreased. - blasts are seen. If scanty (subleukemic). If absent ( Aleukemic leukemia) Schistocytes- DIC (M3)

BMA&B- Hypercellular hyperplastic active Blasts > 30% of nucleated cells Decreased megakaryocytes BM fibrosis (M7) reticulin stain

Chemistry S uric acid increased SLDH increased Serum lysozyme increased

Typing Light microscope – using conventional stains detect blasts shape, nucleus size & shape Blasts in AML look larger with large nucleus, open chromatin with cytoplasmic inclusion bodies (Auer’s rods) Blasts in L1 look homogeneous, small size, high N/C ratio L2 larger, heterogeneous, low N/c ratio L3 large, homogeneous, pale vacuolated cytoplasm, similar to Burkitt NHL cells

Special Stains Sudan Black (SB-B) +ve AML MPO stain +ve AML PAS stain +ve M4,M5, M6, L3 tdT +ve ALL L1&L2 Electron microscopy – detect minimal MPO positivity in perinuclear space, Golgi, endoplasmic reticulum

Immunophenotyping Utilizing Cluster differentiation (CD) Flow cytometry or slide agglutination CD10 – L1 CD3 – T cell ALL CD19- B lineage ALL CD33- myeloid marker CD13- = = = CD41,42 – platelet

Karyotyping & Cytogenetics Chromosomal number & abnormalities Hyperdiploidy , hypodiploidy Dletion, inversion, mutation, translocation Philadelphia chromosome t(9;22)

Molecular Biology Using PCR & FISH BCR/ABL hybrid gene C-myc mutation PML mutation MLL mutation RARA gene over expression FLT3 gene mutation

DDx ALL- Acute Myelogenous Leukemia Lymphoma, B-Cell Lymphoma, High-Grade Malignant Immunoblastic Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Acute biphenotypic leukemia NK-cell leukemia

DDx AML- Acute Lymphoblastic Leukemia Lymphoma, B-Cell Agnogenic Myeloid Metaplasia With Myelofibrosis Lymphoma, Lymphoblastic Agranulocytosis Myelodysplastic Syndrome Myelophthisic Anemia Aplastic Anemia Chronic Myelogenous Leukemia

ALL- L2

ALL- Flow cytometry